{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:44:22Z","timestamp":1792115062600,"version":"4.4.0"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DK062420"],"award-info":[{"award-number":["U01 DK062420"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DK062413"],"award-info":[{"award-number":["U01 DK062413"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DK062432"],"award-info":[{"award-number":["U01 DK062432"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK062422"],"award-info":[{"award-number":["DK062422"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK123758"],"award-info":[{"award-number":["R01 DK123758"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24 DK062429"],"award-info":[{"award-number":["U24 DK062429"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 DK062423"],"award-info":[{"award-number":["U01 DK062423"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>Crohn\u2019s disease [CD] recurrence following ileocolic resection [ICR] is common. We sought to identify blood-based biomarkers associated with CD recurrence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>CD patients undergoing ICR were recruited across six centres. Serum samples were obtained at post-operative colonoscopy. A multiplex immunoassay was used to analyse 92 inflammation-related proteins [Olink Proteomics]. Bayesian analysis was used to identify proteins associated with increasing Rutgeerts score. Identified proteins were used in receiver operating characteristic [ROC] analysis to examine the ability to identify CD recurrence [Rutgeerts score \u2265i2]. Existing single cell data were interrogated to further elucidate the role of the identified proteins.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Data from 276 colonoscopies in 213 patients were available. Median time from surgery to first and second colonoscopy was 7 (interquartile range [IQR] 6\u20139) and 19 [IQR 16\u201323] months, respectively. Disease recurrence was evident at 60 [30%] first and 36 [49%] second colonoscopies. Of 14 proteins significantly associated with Rutgeerts score, the strongest signal was seen for CXCL9 and MMP1. Among patients on anti-tumour necrosis factor drugs, CXCL9 and CXCL11 were most strongly associated with Rutgeerts score. Both are CXCR3 ligands. Incorporation of identified proteins into ROC analysis improved the ability to identify disease recurrence as compared to C-reactive protein alone: area under the curve [AUC] 0.75 (95% confidence interval [CI]: 0.66\u20130.82] vs 0.64 [95% CI 0.56\u20130.72], p = 0.012. Single cell transcriptomic data provide evidence that innate immune cells are the primary source of the identified proteins.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CXCR3 ligands are associated with CD recurrence following ICR. Incorporation of novel blood-based candidate biomarkers may aid in identification of CD recurrence.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjab186","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T19:13:07Z","timestamp":1635189187000},"page":"900-910","source":"Crossref","is-referenced-by-count":33,"title":["A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn\u2019s Disease Recurrence"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8696-354X","authenticated-orcid":false,"given":"Margaret","family":"Walshe","sequence":"first","affiliation":[{"name":"Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System , Toronto, Ontario , Canada"},{"name":"Division of Gastroenterology, Mount Sinai Hospital, Sinai Health System, University of Toronto , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Nayeri","sequence":"additional","affiliation":[{"name":"Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai , New York, NY , USA"},{"name":"The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Hernandez-Rocha","sequence":"additional","affiliation":[{"name":"Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System , Toronto, Ontario , Canada"},{"name":"Division of Gastroenterology, Mount Sinai Hospital, Sinai Health System, University of Toronto , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenija","family":"Sabic","sequence":"additional","affiliation":[{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai , New York, NY , USA"},{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangyuan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai , New York, NY , USA"},{"name":"The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Giri","sequence":"additional","affiliation":[{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai , New York, NY , USA"},{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikha","family":"Nayar","sequence":"additional","affiliation":[{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai , New York, NY , USA"},{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Brant","sequence":"additional","affiliation":[{"name":"Crohn\u2019s and Colitis Center of New Jersey, Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers Robert Wood Johnson Medical School , New Brunswick, NJ , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dermot P B","family":"McGovern","sequence":"additional","affiliation":[{"name":"F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars Sinai Medical Center , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Rioux","sequence":"additional","affiliation":[{"name":"Research Centre, Montreal Heart Institute , Montr\u00e9al, QC , Canada"},{"name":"Faculty of Medicine, Universit\u00e9 de Montr\u00e9al , Montr\u00e9al, QC , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H","family":"Duerr","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh , Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy H","family":"Cho","sequence":"additional","affiliation":[{"name":"The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai , New York, NY , USA"},{"name":"Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil L","family":"Schumm","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Chicago , Chicago, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lazarev","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The John Hopkins Medical Institutions , Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Zane Cohen Centre for Digestive Diseases, Lunenfeld-Tanenbaum Research Institute, Sinai Health System , Toronto, Ontario , Canada"},{"name":"Division of Gastroenterology, Mount Sinai Hospital, Sinai Health System, University of Toronto , Toronto, Ontario , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"2022071420382891000_CIT0001","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"2022071420382891000_CIT0002","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","article-title":"Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies","volume":"145","author":"Frolkis","year":"2013","journal-title":"Gastroenterology"},{"key":"2022071420382891000_CIT0003","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/ajg.2012.298","article-title":"Surgery in a population-based cohort of Crohn\u2019s disease from Olmsted County, Minnesota (1970\u20132004)","volume":"107","author":"Peyrin-Biroulet","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2022071420382891000_CIT0004","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/gut.2010.234617","article-title":"Surgery for adult Crohn\u2019s disease: what is the actual risk?","volume":"60","author":"Bouguen","year":"2011","journal-title":"Gut"},{"key":"2022071420382891000_CIT0005","article-title":"Contemporary","author":"Tsai","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022071420382891000_CIT0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ecco-jcc\/jjz187","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: surgical treatment","volume":"14","author":"Adamina","year":"2020","journal-title":"J Crohns Colitis"},{"key":"2022071420382891000_CIT0007","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","article-title":"Predictability of the postoperative course of Crohn\u2019s disease","volume":"99","author":"Rutgeerts","year":"1990","journal-title":"Gastroenterology"},{"key":"2022071420382891000_CIT0008","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gut.25.6.665","article-title":"Natural history of recurrent Crohn\u2019s disease at the ileocolonic anastomosis after curative surgery","volume":"25","author":"Rutgeerts","year":"1984","journal-title":"Gut"},{"key":"2022071420382891000_CIT0009","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1053\/j.gastro.2016.02.072","article-title":"Infliximab reduces endoscopic, but not clinical, recurrence of Crohn\u2019s disease after ileocolonic resection","volume":"150","author":"Regueiro","year":"2016","journal-title":"Gastroenterology"},{"key":"2022071420382891000_CIT0010","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2036.2012.05002.x","article-title":"Review article: The natural history of postoperative Crohn\u2019s disease recurrence","volume":"35","author":"Buisson","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"2022071420382891000_CIT0011","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","article-title":"3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 2: surgical management and special situations","volume":"11","author":"Gionchetti","year":"2017","journal-title":"J Crohns Colitis"},{"key":"2022071420382891000_CIT0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.gastro.2016.10.038","article-title":"American Gastroenterological Association Institute Guideline on the management of Crohn\u2019s disease after surgical resection","volume":"152","author":"Nguyen","year":"2017","journal-title":"Gastroenterology"},{"key":"2022071420382891000_CIT0013","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(14)61908-5","article-title":"Crohn\u2019s disease management after intestinal resection: a randomised trial","volume":"385","author":"De Cruz","year":"2015","journal-title":"Lancet"},{"key":"2022071420382891000_CIT0014","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/MIB.0000000000001140","article-title":"Comparative acceptability and perceived clinical utility of monitoring tools: a nationwide survey of patients with inflammatory bowel disease","volume":"23","author":"Buisson","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2022071420382891000_CIT0015","first-page":"573","article-title":"Colonoscopic perforation in inflammatory bowel disease","volume":"9","author":"Makkar","year":"2013","journal-title":"Gastroenterol Hepatol"},{"key":"2022071420382891000_CIT0016","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3748\/wjg.v21.i4.1182","article-title":"Optimizing perioperative Crohn\u2019s disease management: role of coordinated medical and surgical care","volume":"21","author":"Bennett","year":"2015","journal-title":"World J Gastroenterol"},{"key":"2022071420382891000_CIT0017","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/17474124.2019.1626717","article-title":"Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn\u2019s disease patients: the Practicrohn study","volume":"13","author":"Barreiro-De Acosta","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2022071420382891000_CIT0018","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/gut.35.2.231","article-title":"Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn\u2019s disease. A prospective multicentre study of 121 cases. The Groupe d\u2019Etudes Th\u00e9rapeutiques des Affections Inflammatoires Digestives","volume":"35","author":"Cellier","year":"1994","journal-title":"Gut"},{"key":"2022071420382891000_CIT0019","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2015.01.026","article-title":"Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn\u2019s disease after surgery","volume":"148","author":"Wright","year":"2015","journal-title":"Gastroenterology"},{"key":"2022071420382891000_CIT0020","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/ajg.2015.30","article-title":"Levels of fecal calprotectin are associated with the severity of postoperative endoscopic recurrence in asymptomatic patients with Crohn\u2019s disease","volume":"110","author":"Boschetti","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2022071420382891000_CIT0021","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1097\/MIB.0000000000000960","article-title":"Fecal calprotectin levels are closely correlated with the absence of relevant mucosal lesions in postoperative Crohn\u2019s disease","volume":"22","author":"Garcia-Planella","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2022071420382891000_CIT0022","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ajg.2009.545","article-title":"Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn\u2019s disease (SES-CD) than CRP, blood leukocytes, and the CDAI","volume":"105","author":"Schoepfer","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2022071420382891000_CIT0023","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/MEG.0000000000001284","article-title":"Fecal calprotectin is not superior to serum C-reactive protein or the Harvey\u2013Bradshaw index in predicting postoperative endoscopic recurrence in Crohn\u2019s disease","volume":"30","author":"Verdejo","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022071420382891000_CIT0024","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cell.2019.08.008","article-title":"Single-cell analysis of Crohn\u2019s disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy","volume":"178","author":"Martin","year":"2019","journal-title":"Cell"},{"key":"2022071420382891000_CIT0025","first-page":"xxi, 358","volume-title":"Multilevel Statistical Models","author":"Goldstein","year":"2011","edition":"4"},{"key":"2022071420382891000_CIT0026","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/apt.14944","article-title":"Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn\u2019s disease: results from a prospective cohort study","volume":"48","author":"Auzolle","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2022071420382891000_CIT0027","volume-title":"Regression Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Frank","year":"2015"},{"key":"2022071420382891000_CIT0028","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F","article-title":"Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians","volume":"19","author":"Carpenter","year":"2000","journal-title":"Stat Med"},{"key":"2022071420382891000_CIT0029","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2022071420382891000_CIT0030","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J Mach Learn Res"},{"key":"2022071420382891000_CIT0031","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1749-6632.1982.tb22126.x","article-title":"Biosynthesis of C-reactive protein","volume":"389","author":"Macintyre","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"2022071420382891000_CIT0032","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1053\/j.gastro.2019.10.034","article-title":"Development and validation of a test to monitor endoscopic activity in patients with Crohn\u2019s disease based on serum levels of proteins","volume":"158","author":"D\u2019Haens","year":"2020","journal-title":"Gastroenterology"},{"key":"2022071420382891000_CIT0033","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2014.11.009","article-title":"CXCR3 ligands in disease and therapy","volume":"26","author":"Van Raemdonck","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"2022071420382891000_CIT0034","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp Cell Res"},{"key":"2022071420382891000_CIT0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","article-title":"CXCR3, inflammation, and autoimmune diseases","volume":"1173","author":"Lacotte","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"2022071420382891000_CIT0036","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/ecco-jcc\/jjy130","article-title":"Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise","volume":"12","author":"Trivedi","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2022071420382891000_CIT0037","first-page":"e206","article-title":"MIG in Crohn\u2019s disease","volume":"170","author":"Caruso","year":"2019","journal-title":"Clin Ter"},{"key":"2022071420382891000_CIT0038","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2249.2011.04382.x","article-title":"Chemokine CXCL11 links microbial stimuli to intestinal inflammation","volume":"164","author":"Liu","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"2022071420382891000_CIT0039","doi-asserted-by":"crossref","first-page":"e0228615","DOI":"10.1371\/journal.pone.0228615","article-title":"Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis","volume":"15","author":"Jodeleit","year":"2020","journal-title":"PLoS One"},{"key":"2022071420382891000_CIT0040","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1440-1746.2008.05486.x","article-title":"Expression of a splice variant of CXCR3 in Crohn\u2019s disease patients; indication for a lymphocyte\u2013epithelial cell interaction","volume":"23","author":"Manousou","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"2022071420382891000_CIT0041","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ibd.23034","article-title":"Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation","volume":"19","author":"Ostvik","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2022071420382891000_CIT0042","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s10620-018-4932-8","article-title":"Loss of response to anti-tumor necrosis factor alpha therapy in Crohn\u2019s disease is not associated with emergence of novel inflammatory pathways","volume":"63","author":"Luther","year":"2018","journal-title":"Dig Dis Sci"},{"key":"2022071420382891000_CIT0043","doi-asserted-by":"crossref","first-page":"e0186142","DOI":"10.1371\/journal.pone.0186142","article-title":"Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles","volume":"12","author":"Andersson","year":"2017","journal-title":"PLoS One"},{"key":"2022071420382891000_CIT0044","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.10.008","article-title":"Chemokine and cytokine levels in inflammatory bowel disease patients","volume":"77","author":"Singh","year":"2016","journal-title":"Cytokine"},{"key":"2022071420382891000_CIT0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00054725-200111000-00001","article-title":"Chemokine receptor CXCR3 expression in inflammatory bowel disease","volume":"7","author":"Yuan","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"2022071420382891000_CIT0046","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9440(10)65128-0","article-title":"Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis","volume":"155","author":"Uguccioni","year":"1999","journal-title":"Am J Pathol"},{"key":"2022071420382891000_CIT0047","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/ibd.21312","article-title":"Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease","volume":"16","author":"Schroepf","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"2022071420382891000_CIT0048","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2249.2010.04290.x","article-title":"Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis","volume":"163","author":"Hosomi","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"2022071420382891000_CIT0049","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bbrc.2007.09.020","article-title":"Association of a CXCL9 polymorphism with pediatric Crohn\u2019s disease","volume":"363","author":"Lacher","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2022071420382891000_CIT0050","doi-asserted-by":"crossref","first-page":"964131","DOI":"10.1155\/2015\/964131","article-title":"Matrix metalloproteinases in inflammatory bowel disease: an update","volume":"2015","author":"O\u2019Sullivan","year":"2015","journal-title":"Mediators Inflamm"},{"key":"2022071420382891000_CIT0051","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2249.2008.03836.x","article-title":"Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium","volume":"155","author":"Pedersen","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2022071420382891000_CIT0052","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000336995","article-title":"The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases","volume":"30","author":"Lakatos","year":"2012","journal-title":"Dig Dis"},{"key":"2022071420382891000_CIT0053","doi-asserted-by":"crossref","first-page":"275072","DOI":"10.1155\/2009\/275072","article-title":"Correlation of plasma MMP-1 and TIMP-1 levels and the colonic mucosa expressions in patients with ulcerative colitis","volume":"2009","author":"Wang","year":"2009","journal-title":"Mediators Inflamm"},{"key":"2022071420382891000_CIT0054","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/gut.47.1.63","article-title":"Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease","volume":"47","author":"von Lampe","year":"2000","journal-title":"Gut"},{"key":"2022071420382891000_CIT0055","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/ajg.2015.120","article-title":"C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"110","author":"Mosli","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"2022071420382891000_CIT0056","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/ibd.21933","article-title":"High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn\u2019s disease: a marker for patient classification?","volume":"18","author":"Kiss","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"2022071420382891000_CIT0057","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","article-title":"Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease","volume":"11","author":"Solem","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2022071420382891000_CIT0058","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818785571","article-title":"Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn\u2019s disease: systematic review and meta-analysis","volume":"11","author":"Tham","year":"2018","journal-title":"Therap Adv Gastroenterol"},{"key":"2022071420382891000_CIT0059","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/MIB.0000000000000262","article-title":"Fecal calprotectin for evaluating postoperative recurrence of Crohn\u2019s disease: a meta-analysis of prospective studies","volume":"21","author":"Qiu","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2022071420382891000_CIT0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2050640614558106","article-title":"The clinical value of faecal calprotectin and lactoferrin measurement in postoperative Crohn\u2019s disease","volume":"3","author":"Yamamoto","year":"2015","journal-title":"United European Gastroenterol J"},{"key":"2022071420382891000_CIT0061","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/MIB.0000000000000955","article-title":"An overview of the innate and adaptive immune system in inflammatory bowel disease","volume":"23","author":"Choy","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"2022071420382891000_CIT0062","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.4049\/jimmunol.171.8.4156","article-title":"Blockade of B7-H1 suppresses the development of chronic intestinal inflammation","volume":"171","author":"Kanai","year":"2003","journal-title":"J Immunol"},{"key":"2022071420382891000_CIT0063","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.celrep.2014.01.020","article-title":"Tissue-expressed B7-H1 critically controls intestinal inflammation","volume":"6","author":"Scandiuzzi","year":"2014","journal-title":"Cell Rep"},{"key":"2022071420382891000_CIT0064","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1053\/j.gastro.2004.02.004","article-title":"The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells","volume":"126","author":"Nakazawa","year":"2004","journal-title":"Gastroenterology"},{"key":"2022071420382891000_CIT0065","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1053\/j.gastro.2008.07.016","article-title":"PD-1 ligand expression by human colonic myofibroblasts\/fibroblasts regulates CD4+ T-cell activity","volume":"135","author":"Pinchuk","year":"2008","journal-title":"Gastroenterology"},{"key":"2022071420382891000_CIT0066","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4049\/jimmunol.0802769","article-title":"Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade","volume":"182","author":"Reynoso","year":"2009","journal-title":"J Immunol"},{"key":"2022071420382891000_CIT0067","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.3389\/fimmu.2018.02618","article-title":"CD137 (4-1BB) Signalosome: complexity is a matter of TRAFs","volume":"9","author":"Zapata","year":"2018","journal-title":"Front Immunol"},{"key":"2022071420382891000_CIT0068","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2249.2005.02991.x","article-title":"Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis","volume":"143","author":"Maerten","year":"2006","journal-title":"Clin Exp Immunol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjab186\/40873427\/jjab186.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/6\/900\/44890521\/jjab186.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/16\/6\/900\/44890521\/jjab186.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T20:40:29Z","timestamp":1657831229000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/16\/6\/900\/6410738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":68,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,10,26]]},"published-print":{"date-parts":[[2022,7,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjab186","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2021,10,26]]}}}